Institutional investors hold a majority ownership of BMY through the 72.99% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2014, these large investors purchased a net $22.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 14.5 Million shares of Bristol-Myers Squibb
JANUS CAPITAL MANAGEMENT LLC Bought 7.7 Million shares of Bristol-Myers Squibb
LORD, ABBETT & CO. LLC Bought 4.1 Million shares of Bristol-Myers Squibb